Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)

SHE:000597 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,421	7,531	7,646	9,051	8,384	6,848
Market Cap Growth	-7.27%	-1.49%	-15.52%	7.95%	22.43%	1.46%
Enterprise Value	5,416	4,778	5,667	7,484	8,815	8,080
Last Close Price	5.20	5.17	5.13	5.95	5.85	4.76
PE Ratio	19.61	18.38	21.33	25.84	84.66	558.71
Forward PE	-	24.86	24.86	24.86	24.86	24.86
PS Ratio	1.08	1.00	0.93	1.03	1.03	0.93
PB Ratio	1.33	1.35	1.48	1.92	1.95	1.66
P/TBV Ratio	1.63	1.68	1.79	2.37	2.42	2.09
P/FCF Ratio	11.88	12.57	21.76	10.47	13.38	40.16
P/OCF Ratio	10.46	9.93	13.03	8.16	11.23	12.00
EV/Sales Ratio	0.79	0.64	0.69	0.85	1.08	1.09
EV/EBITDA Ratio	5.45	4.69	6.22	9.92	12.20	11.64
EV/EBIT Ratio	12.60	10.04	15.48	34.09	41.85	37.84
EV/FCF Ratio	8.67	7.97	16.13	8.66	14.07	47.38
Debt / Equity Ratio	0.33	0.29	0.42	0.47	0.58	0.63
Debt / EBITDA Ratio	1.87	1.53	2.32	2.81	3.27	3.74
Debt / FCF Ratio	2.98	2.66	6.21	2.54	3.97	15.25
Asset Turnover	0.49	0.51	0.57	0.65	0.64	0.60
Inventory Turnover	3.55	3.53	3.97	4.50	4.04	3.62
Quick Ratio	0.95	0.87	0.86	0.78	0.65	0.57
Current Ratio	1.12	1.05	1.02	0.94	0.83	0.76
Return on Equity (ROE)	6.65%	7.89%	7.62%	7.93%	2.27%	0.27%
Return on Assets (ROA)	1.91%	2.00%	1.57%	1.02%	1.04%	1.08%
Return on Invested Capital (ROIC)	9.26%	15.47%	11.86%	4.09%	3.53%	0.47%
Return on Capital Employed (ROCE)	6.90%	7.70%	6.40%	4.10%	4.20%	4.40%
Earnings Yield	5.05%	5.44%	4.69%	3.87%	1.18%	0.18%
FCF Yield	8.42%	7.96%	4.59%	9.55%	7.47%	2.49%
Dividend Yield	1.94%	1.93%	1.95%	1.68%	0.24%	0.17%
Payout Ratio	58.19%	50.30%	61.31%	31.25%	167.14%	1019.51%
Buyback Yield / Dilution	1.21%	1.43%	-2.34%	0.97%	-15.42%	8.41%
Total Shareholder Return	3.15%	3.37%	-0.40%	2.65%	-15.18%	8.58%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.